Fesarius Therapeutics
PrivateLast Round
Series A
Jun 10, 2026
Total Funding Raised
$28.63M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Fesarius Therapeutics is a bioregenerative medical technology company that develops solutions for wound care, reconstructive surgery, and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fesarius Therapeutics Comparables
Compare Fesarius Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omeza | 81% | |
| MedSkin Solutions Dr. Suwelack | 79% | |
| Aroa Biosurgery | 78% |
Fesarius Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 10, 2026 | ||||
| Convertible Debt | Nov 1, 2023 | ||||
| Grant | Aug 16, 2023 | ||||
| Grant | Aug 8, 2023 |
Key People
Founding team and executive leadership
Fesarius Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| NIH RADx | Grant |
| Jefferson Life Sciences | Series A |
| American Society of Plastic Surgeons | Series A |
| Johnson & Johnson Innovation - JJDC | Series A |
| ASPS Ventures, LLC | Series A |
| New York Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 19, 2026
Grew 20% QoQ, from 15 to 18 employees.
- Jun 10, 2026
$20M round led by Jefferson Life Sciences.
Fesarius Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Fesarius Therapeutics's valuation, stock price, and market status.
Is Fesarius Therapeutics a public or private company?
Fesarius Therapeutics is a private company.
What is the current stock price of Fesarius Therapeutics?
Fesarius Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Fesarius Therapeutics worth (valuation)?
Valuation information for Fesarius Therapeutics is not publicly available.
Can I buy Fesarius Therapeutics stock?
Fesarius Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Fesarius Therapeutics's last funding round?
Fesarius Therapeutics's most recent funding round was Series A on June 10, 2026.
Who are the main investors in Fesarius Therapeutics?
Key investors in Fesarius Therapeutics include Jefferson Life Sciences.
Will Fesarius Therapeutics IPO soon?
No public IPO plans have been announced for Fesarius Therapeutics.
How can I track Fesarius Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fesarius Therapeutics's secondary market activity and sign up for updates.